5-(6-chloroimidazo[1,2-a]pyridin-3-yl)-3-(4-methylphenyl)-1,2,4-oxadiazole

C16H11ClN4O — CID 163693237

IUPAC5-(6-chloroimidazo[1,2-a]pyridin-3-yl)-3-(4-methylphenyl)-1,2,4-oxadiazole
SMILESCc1ccc(-c2noc(-c3cnc4ccc(Cl)cn34)n2)cc1
InChIInChI=1S/C16H11ClN4O/c1-10-2-4-11(5-3-10)15-19-16(22-20-15)13-8-18-14-7-6-12(17)9-21(13)14/h2-9H,1H3
InChIKeyHRHLXZRNZVUCNI-UHFFFAOYSA-N
MW310.74 g/mol
LogP4.01
Rot. Bonds2

About 5-(6-chloroimidazo[1,2-a]pyridin-3-yl)-3-(4-methylphenyl)-1,2,4-oxadiazole

5-(6-chloroimidazo[1,2-a]pyridin-3-yl)-3-(4-methylphenyl)-1,2,4-oxadiazole (PubChem CID 163693237) has the molecular formula C16H11ClN4O and a molecular weight of 310.74 g/mol. Its IUPAC name is 5-(6-chloroimidazo[1,2-a]pyridin-3-yl)-3-(4-methylphenyl)-1,2,4-oxadiazole.

Molecular Properties

Compound Name5-(6-chloroimidazo[1,2-a]pyridin-3-yl)-3-(4-methylphenyl)-1,2,4-oxadiazole
PubChem CID163693237
Molecular FormulaC16H11ClN4O
Molecular Weight310.74 g/mol
Exact Mass310.06
IUPAC Name5-(6-chloroimidazo[1,2-a]pyridin-3-yl)-3-(4-methylphenyl)-1,2,4-oxadiazole
SMILESCc1ccc(-c2noc(-c3cnc4ccc(Cl)cn34)n2)cc1
InChIInChI=1S/C16H11ClN4O/c1-10-2-4-11(5-3-10)15-19-16(22-20-15)13-8-18-14-7-6-12(17)9-21(13)14/h2-9H,1H3
InChIKeyHRHLXZRNZVUCNI-UHFFFAOYSA-N
XLogP4.01
TPSA56.22 Ų
H-Bond Donors
H-Bond Acceptors5
Rotatable Bonds2
Heavy Atoms22
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500310.74
LogP ≤ 54.01
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 105

Analyze 5-(6-chloroimidazo[1,2-a]pyridin-3-yl)-3-(4-methylphenyl)-1,2,4-oxadiazole with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

3-phenyl-5-[6-[4-(trifluoromethyl)phenyl]imidazo[1,2-a]pyridin-3-yl]-1,2,4-oxadiazole
CID 141167616
3-(6-methylimidazo[1,2-a]pyridin-3-yl)-5-(1H-pyrazol-5-yl)-1,2,4-oxadiazole
CID 154807766
5-(3-chloro-4-methylphenyl)-3-(4-methylphenyl)-1,2,4-oxadiazole
CID 931247
3-(4-chlorophenyl)-5-methyl-1,2,4-oxadiazole
CID 684002
3-(4-chlorophenyl)-5-(4-methylpyrimidin-5-yl)-1,2,4-oxadiazole
CID 99963017
N-methyl-2-[3-[3-(6-methylimidazo[1,2-a]pyridin-3-yl)-1,2,4-oxadiazol-5-yl]phenoxy]ethanamine
CID 167937639
3-(4-methylphenyl)-5-(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)-1,2,4-oxadiazole
CID 75527949
3-(4-bromophenyl)-5-(4-methylphenyl)-1,2,4-oxadiazole
CID 752268
4-[4-(6-chloroimidazo[1,2-a]pyridin-3-yl)-5-methylpyrimidin-2-yl]morpholine
CID 153331476
5-(2-methylphenyl)-3-(4-methylphenyl)-1,2,4-oxadiazole
CID 867102
5-[3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl]pyridin-2-amine
CID 63260076
6-chloro-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-amine
CID 63618450

Frequently Asked Questions

What is the IUPAC name of 5-(6-chloroimidazo[1,2-a]pyridin-3-yl)-3-(4-methylphenyl)-1,2,4-oxadiazole?
The IUPAC name of 5-(6-chloroimidazo[1,2-a]pyridin-3-yl)-3-(4-methylphenyl)-1,2,4-oxadiazole (CID 163693237) is 5-(6-chloroimidazo[1,2-a]pyridin-3-yl)-3-(4-methylphenyl)-1,2,4-oxadiazole.
What is the SMILES notation for 5-(6-chloroimidazo[1,2-a]pyridin-3-yl)-3-(4-methylphenyl)-1,2,4-oxadiazole?
The canonical SMILES for 5-(6-chloroimidazo[1,2-a]pyridin-3-yl)-3-(4-methylphenyl)-1,2,4-oxadiazole is Cc1ccc(-c2noc(-c3cnc4ccc(Cl)cn34)n2)cc1.
What is the InChIKey of 5-(6-chloroimidazo[1,2-a]pyridin-3-yl)-3-(4-methylphenyl)-1,2,4-oxadiazole?
The InChIKey is HRHLXZRNZVUCNI-UHFFFAOYSA-N. The full InChI is InChI=1S/C16H11ClN4O/c1-10-2-4-11(5-3-10)15-19-16(22-20-15)13-8-18-14-7-6-12(17)9-21(13)14/h2-9H,1H3.
What are the key properties of 5-(6-chloroimidazo[1,2-a]pyridin-3-yl)-3-(4-methylphenyl)-1,2,4-oxadiazole?
5-(6-chloroimidazo[1,2-a]pyridin-3-yl)-3-(4-methylphenyl)-1,2,4-oxadiazole has a molecular weight of 310.74 g/mol, XLogP of 4.01, 2 rotatable bonds, 0 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 5-(6-chloroimidazo[1,2-a]pyridin-3-yl)-3-(4-methylphenyl)-1,2,4-oxadiazole is sourced from PubChem (CID 163693237), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).